Weight | 588.666 g/mol |
---|---|
Formula | C27H40N8O7 |
Hydrogen Acceptors | 7 |
Hydrogen Donors | 7 |
Aromatic Rings | 1 |
Rotatable Bonds | 9 |
Cilengitide (188968-51-6)
"What do you need help with?"
LabBot
- Sigma-Aldrich - Search for Cilengitide
- Fisher Scientific - Search for Cilengitide
- TCI - Search for Cilengitide
- Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme (Journal of Clinical Oncology, 2008)
- Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma (Journal of Clinical Oncology, 2010)
- Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation (Anti-cancer Agents in Medicinal Chemistry, 2010)
- Phase I and Correlative Biology Study of Cilengitide in Patients With Recurrent Malignant Glioma (Journal of Clinical Oncology, 2007)
- Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial (Lancet Oncology, 2014)
- Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins v3 and v5 in patients with advanced solid tumours (European Journal of Cancer, 2003)
-
Including Acute Oral Tox, Skin Sensitization, Eye Irritation, Aquatic Tox, & more. -
SMILESCC(C)C1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1C)CC2=CC=CC=C2)CC(=O)O)CCCN=C(N)N
-
InChIKeyAMLYAMJWYAIXIA-UHFFFAOYSA-N
- Pubchem - Cilengitide
- Wikipedia - cilengitide
Cilengitide (EMD 121974) is a molecule designed and synthesized at the Technical University Munich in collaboration with Merck KGaA in Darmstadt. It is based on the cyclic peptide cyclo(-RGDfV-), which is selective for v integrins, which are important in angiogenesis (forming new blood vessels), and other aspects of tumor biology. Hence, it is under investigation for the treatment of glioblastoma, where it may act by inhibiting angiogenesis, and influencing tumor invasion and proliferation.
Suppliers
Most-cited Publications
Areas of Application
Safety
Alternate Names
External Links
Similar Compounds
Eptifibatide
(188627-80-7)
1 alternate name
3 suppliers
Chloropeptide
(12663-46-6)
1 alternate name
3 suppliers
sulfometuron-methyl
(74222-97-2)
1 alternate name
3 safety hazards
3 suppliers
PERINDOPRIL ERBUMINE
(107133-36-8)
1 alternate name
3 suppliers
Bensulfuron methyl
(83055-99-6)
1 alternate name
1 safety hazard
3 suppliers
OCHRATOXIN A
(303-47-9)
1 alternate name
3 suppliers
hyperforin
(11079-53-1)
1 alternate name
3 suppliers
suxibuzone
(27470-51-5)
1 alternate name
3 suppliers
VIOMYCIN
(32988-50-4, 37883-00-4)
1 alternate name
3 suppliers
hiperforina
(11079-53-1)
1 alternate name
3 suppliers
FLUCYTHRINATE
(70124-77-5)
1 alternate name
3 suppliers
Folcysteine
(8064-47-9)
1 alternate name
3 suppliers
OCHRATOXIN B
(4825-86-9)
1 alternate name
3 suppliers
Antimycin A
(1397-94-0, 642-15-9, 116095-18-2)
1 alternate name
3 suppliers
antimycin A1
(1397-94-0, 642-15-9)
1 alternate name
3 suppliers
Enterostatin
(9001-78-9, 117830-79-2)
1 alternate name
3 suppliers
54849-38-6
(54849-38-6)
1 alternate name
3 suppliers
fenvalerate
(51630-58-1, 66267-77-4, 67614-33-9, 67614-32-8)
1 alternate name
4 safety hazards
3 suppliers
303-47-9
(303-47-9)
1 alternate name
3 suppliers
CYFLUTHRIN
(68359-37-5)
1 alternate name
6 safety hazards
3 suppliers
Totm
(3319-31-1, 82643-26-3)
1 alternate name
3 suppliers
METSULFURON-METHYL
(74223-64-6)
1 alternate name
2 safety hazards
3 suppliers
3319-31-1
(3319-31-1)
1 alternate name
3 suppliers
3319-31-1
(3319-31-1)
1 alternate name
3 suppliers
3319-31-1
(3319-31-1)
1 alternate name
3 suppliers
3319-31-1
(3319-31-1)
1 alternate name
3 suppliers
Blasticidin S
(2079-00-7)
1 alternate name
3 safety hazards
3 suppliers
aztreonam
(78110-38-0)
1 alternate name
3 suppliers
Tolterodine tartrate
(124937-52-6)
1 alternate name
3 suppliers
Azthreonam
(85506-30-5, 78110-38-0)
1 alternate name
3 suppliers
AMPICILLIN SODIUM
(69-52-3)
1 alternate name
3 suppliers
AMPICILLIN SODIUM
(69-52-3)
1 alternate name
3 suppliers
UNII-5Q55M3D9UA
(99341-02-3, 78110-38-0)
1 alternate name
3 suppliers
DSSTox_CID_2640
(78110-38-0)
1 alternate name
3 suppliers
4,4'-METHYLENEBIS(2,6-DI-TERT-BUTYLPHENOL)
(118-82-1)
1 alternate name
3 suppliers
Leupeptin
(103476-89-7, 24365-47-7, 55123-66-5)
1 alternate name
3 suppliers
85506-30-5
(85506-30-5, 78110-38-0)
1 alternate name
3 suppliers
Phenylalanylphenylalanine
(2577-40-4)
1 alternate name
3 suppliers
Tetrahydrocurcumin
(36062-04-1)
1 alternate name
3 suppliers
cypermethrin
(52315-07-8, 67375-30-8, 97955-44-7)
1 alternate name
11 safety hazards
3 suppliers
PYRETHRIN II
(121-29-9)
1 alternate name
4 safety hazards
3 suppliers
Enalapril maleate
(75847-73-3, 76095-16-4, 76420-75-2)
1 alternate name
3 suppliers
Alphamethrin
(65731-84-2, 67375-30-8)
1 alternate name
6 safety hazards
3 suppliers
Alphamethrin
(72204-44-5, 67375-30-8)
1 alternate name
6 safety hazards
3 suppliers
alpha-cypermethrin
(72204-44-5, 67375-30-8)
1 alternate name
6 safety hazards
3 suppliers
QUINAPRIL HYDROCHLORIDE
(82586-55-8)
1 alternate name
3 suppliers
Tebufenozide
(112410-23-8, 142583-69-5)
1 alternate name
4 safety hazards
3 suppliers
Vitamin E acetate
(7695-91-2, 52225-20-4, 58-95-7)
1 alternate name
3 suppliers
AMPICILLIN TRIHYDRATE
(7177-48-2)
1 alternate name
3 suppliers
MOEXIPRIL HYDROCHLORIDE
(82586-52-5)
1 alternate name
3 suppliers
Diethylstilbestrol dipropionate
(37221-14-0, 130-80-3)
1 alternate name
3 suppliers
Tricaprin
(621-71-6)
1 alternate name
3 suppliers
TRILAURIN
(538-24-9)
1 alternate name
3 suppliers
vitamin e succinate
(4345-03-3, 17407-37-3)
1 alternate name
3 suppliers
diaziquone
(57998-68-2)
1 alternate name
3 suppliers
alpha-tochopheryl acetate
(7695-91-2, 58-95-7)
1 alternate name
3 suppliers
Prosulfuron
(94125-34-5)
1 alternate name
2 safety hazards
3 suppliers
CAS Directory